Please login to the form below
6
Revenue 2017Johnson & Johnson
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Johnson & Johnson's 2013 sales performance.
UK supercharges booster programme over Omicron
In a Sunday evening televised announcement, Prime Minister Boris Johnson set a new target to give boosters to all adults who wanted one by the end of December in response to
Mix-and-match COVID-19 vaccines may be more effective
Johnson &Johnson (J&J) has released preliminary results from a small phase 2 study that show a booster shot of its COVID-19 vaccine, Ad26.COV2.S, not only elicits a ... These T-cell response data suggest differences between immune responses following
Booster plans expanded to combat Omicron
Johnson &Johnson shot.
COVID-19 vaccines against Omicron may be fast-tracked
In the last few days, Pfizer-BioNTech, Moderna and Johnson &Johnson have all announced that they have begun work on Omicron-specific versions of their existing vaccines.
A Life in a Day - Building Empathy to Support Patient Centric Goals
by Attigo, supported by Johnson and Johnson, The Department for International Development and Yale University. ... Mental Health Empowerment - by Attigo, supported by Johnson and Johnson, The Department for International Development and Yale University.
[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
Subscribe to our email news alerts
Featured jobs
- Country Manager, Healthcare Communications Agency, Germany
-
Highly competitive salary
- Sanofi halts recruitment for trials assessing MS treatment
- bluebird bio reveals plans to launch two gene therapies
- ONS data reveals significant decrease in COVID-19 antibodies
- AbbVie and Sosei Heptares collaborate in new agreement worth up to $1.2bn
- Eli Lilly to make bebtelovimab commercially available to US states from August
- ONS records a continued fall in UK COVID-19 infections
- Engaging KOLs and Gaining Insights in Pharma's New Normal
- That ‘don’t’ impress me much
- Bristol Myers Squibb and GentiBio in $1.9bn deal to develop IBD therapies
- Novartis’ Pluvicto receives MHRA marketing authorisation to treat advanced prostate cancer
- AstraZeneca and Daiichi Sankyo receive FDA approval for lung cancer drug
- ONS data reveals significant decrease in COVID-19 antibodies
- AbbVie and Sosei Heptares collaborate in new agreement worth up to $1.2bn
- Roche shares new positive Ocrevus data for MS patients
- AstraZeneca and MSD’s breast cancer drug Lynparza receives EC approval
- NHS App to revolutionise digital health and care with major digital updates by 2023
- Medical Affairs: centre-stage in scientific engagement strategies
- ALL SYSTEMS GO: UNDERSTANDING WHO’S WHO IN THE NEW NHS LANDSCAPE
PMHub
Mednet Group
PMEA Agency of the year 2021. With diversity and inclusion at our core, Mednet Group consists of Attigo CIC and...
Latest intelligence
- The communication challenge of helping he next generation to be healthier
- As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
- Are we losing sight of what the democratisation of healthcare really looks like?
- We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...
- How the Royal Society’s EiR programme can help to drive UK innovation
- ...
